bismuth subsalicylate cas 14882-18-9

Bismuth Subsalicylate (CAS 14882-18-9) Comprehensive Guide

Product Specifications & Comparative Analysis

Industrial & Pharmaceutical Applications

1. Gastrointestinal Therapeutics
Primary active component in anti-diarrheal formulations (e.g., Pepto-Bismol^®), demonstrating:

• Antimicrobial action against Helicobacter pylori
• Mucosal protective properties
• Anti-inflammatory effects

2. Chemical Synthesis
Utilized as:

• Catalyst in organic reactions
• Precursor for bismuth-containing compounds
• Stabilizer in polymer production

Functional Use Cases

Pharmaceutical Manufacturing
Dose formulation parameters:

• Standard suspension concentration: 262 mg/15 mL
• Tablet formulation: 300-525 mg/dose
• Typical treatment duration: ≤48 hours

Industrial Catalysis
Operational protocols:

• Optimal reaction temperature: 80-120°C
• Catalytic loading: 0.5-2 mol%
• Compatibility with polar aprotic solvents

Client Case Studies

Case 1: Pharmaceutical Producer (Hubei, China)
Requirements:
– Batch production of 5MT/month
– USP-grade purity (≥99%)
Solution:
Implemented closed-loop synthesis system achieving 99.2% purity with <2% batch variance.

Case 2: European Research Consortium
Requirements:
– 50kg analytical-grade material
– Particle size distribution ≤50µm
Solution:
Delivered micronized powder with D90=47.3µm, meeting ISO 9001:2015 standards.

Technical Consultation & Quotation

Request customized solutions:

• Email: info@vivalr.com
• Tel: (86) 15866781826

Specification requirements:

• Target purity level
• Packaging specifications
• Quantity requirements
• Application context